Gilead Sciences | GILD - EPS Earnings Per Share

Gilead Sciences reported $1.72 in EPS Earnings Per Share for its fiscal quarter ending in December of 2023.

Fiscal Calendar Actual Consensus Previous Date
FY2024Q1 Mar/2024 3.34 1.56 1.37 Apr/25 2024
FY2023Q4 Dec/2023 1.72 1.76 1.67 Feb/06 2024
FY2023Q3 Sep/2023 2.29 1.91 1.90 Nov/07 2023
FY2023Q2 Jun/2023 1.66 1.64 1.58 Aug/03 2023
FY2023Q1 Mar/2023 1.37 1.51 2.12 Apr/27 2023
FY2022Q4 Dec/2022 1.67 1.50 0.69 Feb/02 2023
FY2022Q3 Sep/2022 1.9 1.42 2.65 Oct/27 2022
FY2022Q2 Jun/2022 1.58 1.52 1.87 Aug/02 2022
FY2022Q1 Mar/2022 2.12 1.84 2.08 Apr/28 2022
FY2021Q4 Dec/2021 0.69 1.68 2.19 Feb/01 2022
FY2021Q3 Sep/2021 2.65 1.78 2.11 Oct/28 2021
FY2021Q2 Jun/2021 1.87 1.75 1.11 Jul/29 2021

Eps Change Date
AbbVie USD 2.79 0.16 Dec/2023
Agios Pharmaceuticals USD -1.72 0.08 Dec/2023
ALKERMES USD 0.22 0.42 Dec/2023
Alnylam Pharmaceuticals USD -1.1 2.25 Dec/2023
Amgen USD 4.71 0.25 Dec/2023
Biogen USD 3.67 0.37 Mar/2024
BioMarin Pharmaceutical USD 0.71 0.53 Mar/2024
Bristol-Myers Squibb USD -4.4 6.1 Mar/2024
Eli Lilly USD 2.49 2.39 Dec/2023
Gilead Sciences USD 1.72 0.57 Dec/2023
GlaxoSmithKline GBP 0.29 0.22 Dec/2023
Glaxosmithkline USD 0.72 0.56 Dec/2023
Incyte USD 1.06 0.04 Dec/2023
J&J USD 2.71 0.42 Mar/2024
Merck USD 2.07 2.04 Mar/2024
Moderna USD 0.55 10.08 Dec/2023
Neurocrine Biosciences USD 1.44 0.62 Dec/2023
Novartis USD 1.8 0.27 Mar/2024
Pfizer USD 0.1 0.27 Dec/2023
PTC Therapeutics USD -1.2 0.96 Mar/2024
Regeneron Pharmaceuticals USD 11.86 0.27 Dec/2023
Sanofi EUR 1.66 0.89 Dec/2023
Sarepta Therapeutics USD 0.47 0.93 Dec/2023
United Therapeutics USD 4.36 1.02 Dec/2023
Vertex Pharmaceuticals USD 4.2 0.12 Dec/2023